English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Purpose: This work aims to introduce a method to quantify and assess the differences in monitor unites MUs when changing to new dose calculation software that uses a different algorithm, and to evaluate the need and extent of adjustment of the prescribed dose to maintain the same clinical results. Methods: Doses were calculated using two classical algorithms based on the Pencil Beam Convolution PBC model, using 6 patients presenting lung cancers. For each patient, 3 treatment plans were generated: Plan 1 was calculated using reference algorithm PBC without heterogeneity correction, Plan 2 was calculated using test algorithm with heterogeneity correction, and in plan 3 the dose was recalculated using test algorithm and monitor unites MUs obtained from plan 1 as input. To assess the differences in the calculated MUs, isocenter dose, and spatial dose distributions using a gamma index were compared. Statistical analysis was based on a Wilcoxon signed rank test. Results: The test algorithm in plan 2 calculated significantly less MUs than reference algorithm in plan 1 by on average 5%, (p < 0.001). We also found underestimating dose for target volumes using 3D gamma index analysis. In this example, in order to obtain the same clinical outcomes with the two algorithms the prescribed dose should be adjusted by 5%. Conclusion: This method provides a quantitative evaluation of the differences between two dose calculation algorithms and the consequences on the prescribed dose. It could be used to adjust the prescribed dose when changing calculation software to maintain the same clinical results as obtained with the former software. In particular, the gamma evaluation could be applied to any situation where changes in the dose calculation occur in radiotherapy.

A decision tool to adjust the prescribed dose after change in the dose calculation algorithm